Specification builder · Tier B
Coagulation analyser for PT/INR, APTT, fibrinogen, D-dimer and other haemostasis tests on citrated plasma: semi-automatic 4-channel as basic, fully automatic 50-150+ PT tests/hour as standard, 350+ PT tests/hour with cap piercing as advanced
An IVD analyser that measures how fast citrated plasma clots (PT/INR, APTT, fibrinogen, thrombin time) and, on fully automatic models, D-dimer, antithrombin, factor levels and heparin activity. Semi-automatic coagulometers are bought by THQ hospitals and small private labs; fully automatic analysers by DHQ, private and teaching hospital labs, cardiac institutes and haemophilia centres in Pakistan. Correct INR for warfarin patients depends as much on the reagent, its ISI and correct citrate tubes as on the analyser, and reagents decide the real cost over its life.
What this equipment will do
- Samples: platelet-poor citrated plasma from 3.2 % citrate blood tubes filled to the line (CLSI H21-A5).
- Prothrombin time in seconds and INR for warfarin patients, using the reagent's instrument-specific ISI and the local mean normal PT (WHO TRS 979 Annex 6, CLSI H47-A2).
- APTT (with stated heparin and factor-deficiency sensitivity), Clauss fibrinogen and thrombin time, for pre-operative, obstetric and bleeding checks.
- Quantitative D-dimer, with a cut-off stated for excluding deep vein thrombosis or pulmonary embolism (CLSI H59-A). (with the optional module)
- Antithrombin and factor VIII and IX levels for bleeding and haemophilia patients. (with the optional module)
- Thrombophilia work-up: protein C, protein S and lupus anticoagulant (dRVVT screen and confirm). (with the optional module)
- Heparin monitoring by anti-Xa for unfractionated and low molecular weight heparin. (with the optional module)
- Von Willebrand factor antigen and activity. (with the optional module)
- Factors II, V, VII, X, XI and XII and factor VIII/IX inhibitor (Bethesda) testing. (with the optional module)
- Platelet aggregation (light transmission) with ADP, collagen, epinephrine, arachidonic acid and ristocetin. (with the optional module)
- Sample quality checks: haemolysis, icterus and lipaemia, under-filled tubes and clots, with the clotting curve of every result stored and flagged. (with the optional module)
- Two-way connection to the laboratory information system (ASTM E1381/E1394 or HL7 v2.x), with delta checks on INR and reflex testing where middleware is ordered. (with the optional module)
Not covered: Platelet count and complete blood count need a haematology analyser.; Whole-blood viscoelastic clotting tests for bleeding in theatre or trauma, and bedside activated clotting time (ACT) in the cath lab, need point-of-care haemostasis devices.; Genetic thrombophilia tests (factor V Leiden, prothrombin gene mutation) need a molecular (PCR) laboratory.
Loading the builder...
Standards this specification draws on
- IEC 61010-1 Basic electrical, mechanical and fire safety for laboratory equipment, including IVD analysers.
- IEC 61010-2-101 Particular safety requirements for IVD medical equipment such as coagulation analysers (moving probes, biohazardous plasma, user information).
- IEC 61326-2-6 EMC requirements for IVD equipment, so optical and mechanical clot detection is not disturbed by mains noise and nearby equipment.
- ISO 13485:2016 Quality management system standard for the manufacturer of the analyser and its reagents.
- ISO 14971:2019 Risk management for medical devices, including IVD analysers and their software.
- ISO 15189:2022 Medical laboratory accreditation standard; requires verification of performance, internal QC, EQA and traceability before patient use.
- CLSI H21-A5 Collection, transport and processing of citrated blood for plasma-based coagulation tests (3.2% citrate, fill volume, platelet-poor plasma, sample stability).
- CLSI H47-A2 Performance of one-stage PT and APTT tests, including reagent sensitivity and mean normal PT.
- CLSI H57-A Protocol for evaluating, validating and implementing coagulometers in the laboratory.
- CLSI H59-A Quantitative D-dimer assays used to exclude venous thromboembolism: cut-off validation and reporting units.
- WHO TRS 979 Annex 6 WHO guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists (ISI calibration and INR).
- DRAP Medical Devices Rules 2017 Pakistan law requiring registration or enlistment of IVD analysers and their reagents before import and sale.
Common mistakes in tenders for this equipment
- Naming one maker's clot detection principle (for example only mechanical or only optical) as a requirement, which excludes other makers without improving results; ask for measured precision and declared interference limits instead.
- Comparing only the analyser price: reagents, calibrators, controls and cuvettes cost more than the analyser within a few years. Evaluate the 5-year cost per reportable test for the lab's real mix of PT, APTT, fibrinogen and D-dimer, including QC, reruns and dead volume.
- Accepting INR results without checking the ISI for the exact analyser and reagent lot or measuring the local mean normal PT, so warfarin patients are dosed on wrong INR values.
- Registering only the analyser with DRAP but not every reagent, control and calibrator, leading to customs holds and stock-outs of single tests such as D-dimer after installation.
- Ignoring pre-analytics: no 3.2% citrate tubes, no centrifuge able to give platelet-poor plasma and no training for ward staff, so under-filled or clotted samples give falsely prolonged or normal results.
- Asking for a D-dimer without stating the reporting unit (FEU or DDU) and whether the cut-off is validated to exclude venous thromboembolism, so clinicians apply the wrong cut-off.
- Buying a single fully automatic analyser for a 24/7 hospital with no backup method, so PT/INR and APTT stop during every breakdown.
- Large vial sizes with short opened-vial stability for rarely ordered tests (factor assays, anti-Xa) in a small lab, so most of each vial expires and the real cost per test doubles.
